IFNA16
IFNA16
IFNA16 is a gene that encodes a member of the interferon family, specifically the type I interferons. Interferons are proteins that are part of the immune response, playing a crucial role in the defense against viral infections and in the regulation of the immune system.
Structure[edit]
The IFNA16 gene is located on the short arm of chromosome 9 in humans. It is part of a cluster of interferon alpha genes, which are known for their antiviral activities. The gene encodes a protein that is secreted by cells in response to viral infections and other stimuli.
Function[edit]
The protein product of the IFNA16 gene is an interferon alpha subtype. Interferon alphas are cytokines that have antiviral, antiproliferative, and immunomodulatory effects. They bind to specific receptors on the surface of cells, initiating a signaling cascade that leads to the expression of numerous interferon-stimulated genes (ISGs). These ISGs help to establish an antiviral state in the cell, inhibiting viral replication and spread.
Clinical Significance[edit]
Interferons, including those encoded by IFNA16, are used therapeutically in the treatment of various diseases. For example, recombinant interferon alpha is used in the treatment of chronic hepatitis C, hepatitis B, and certain types of cancer, such as melanoma and leukemia.
The expression of IFNA16 and other interferon genes can be dysregulated in certain autoimmune diseases, such as systemic lupus erythematosus (SLE), where an overactive interferon response contributes to disease pathology.
Research[edit]
Ongoing research is focused on understanding the specific roles of different interferon alpha subtypes, including IFNA16, in immune responses and their potential therapeutic applications. Studies are also investigating the genetic regulation of IFNA16 expression and its impact on disease susceptibility and progression.
Also see[edit]
| Lymphocytic adaptive immune system and complement | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian